Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Bertram Ottillinger"'
Autor:
Götz Ehlerding, Wolfgang Ries, Manuela Kempkes-Koch, Ekkehard Ziegler, Petra Ronová, Mária Krizsán, Jana Verešová, Mária Böke, Ansgar Erlenkötter, Robert Nitschel, Adam M. Zawada, James P. Kennedy, Jennifer Braun, John W. Larkin, Natalia Korolev, Thomas Lang, Bertram Ottillinger, Manuela Stauss-Grabo, Bettina Griesshaber
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-12 (2024)
Abstract Background Hemodialyzers should efficiently eliminate small and middle molecular uremic toxins and possess exceptional hemocompatibility to improve well-being of patients with end-stage kidney disease. However, performance and hemocompatibil
Externí odkaz:
https://doaj.org/article/4b66a40a5a4e402184c83ded7f823087
Autor:
Thomas Lang, Adam M. Zawada, Lukas Theis, Jennifer Braun, Bertram Ottillinger, Pascal Kopperschmidt, Alfred Gagel, Peter Kotanko, Manuela Stauss-Grabo, James P. Kennedy, Bernard Canaud
Publikováno v:
Bioengineering, Vol 10, Iss 2, p 145 (2023)
Despite the significant medical and technical improvements in the field of dialytic renal replacement modalities, morbidity and mortality are excessively high among patients with end-stage kidney disease, and most interventional studies yielded disap
Externí odkaz:
https://doaj.org/article/fe1130883d0345e8bb4f15a1b0c707ba
Autor:
Adam M. Zawada, Thomas Lang, Bertram Ottillinger, Fatih Kircelli, Manuela Stauss-Grabo, James P. Kennedy
Publikováno v:
Membranes, Vol 12, Iss 10, p 932 (2022)
The dialyzer is the core element in the hemodialysis treatment of patients with end-stage kidney disease (ESKD). During hemodialysis treatment, the dialyzer replaces the function of the kidney by removing small and middle-molecular weight uremic toxi
Externí odkaz:
https://doaj.org/article/4de7d31bd0604570a06efc0aaf9abaf7
Autor:
Ekkehard Ziegler, Ansgar Erlenkötter, Bertram Ottillinger, Wolfgang Ries, Adam M Zawada, Manuela Kempkes-Koch, Thomas Lang, Götz Ehlerding, Manuela Stauss-Grabo, James Kennedy
Publikováno v:
Clinical kidney journal. 15(4)
Background Dialyzers should be designed to efficiently eliminate uraemic toxins during dialysis treatment, given that the accumulation of small and middle molecular weight uraemic solutes is associated with increased mortality risk of patients with e
Autor:
Alexander Kucera, Milos Barna, Marie Hladíková, Ondrej Horacek, Bertram Ottillinger, Simona Holcova
Publikováno v:
International Journal of Pediatrics and Adolescent Medicine, Vol 5, Iss 4, Pp 135-141 (2018)
International Journal of Pediatrics & Adolescent Medicine
International Journal of Pediatrics & Adolescent Medicine
Objective: The safety of comfrey herbal cream application to broken skin is still a matter of regulatory debate. It was therefore examined in children with intact and with broken skin treated for blunt traumas and sports injuries, with the aim of col
Autor:
Natalya Benderska-Söder, Ekkehardt Bismarck, Roland Starlinger, Carsten Lange, Bertram Ottillinger, Oliver W. Hakenberg, Stephan Mühlich, Bernd J. Schmitz-Dräger
Publikováno v:
Urol Int
Background: Observational studies generate information on real-world therapy and complement data from prospective randomized trials. LEAN is an open-label, non-interventional, multi-centre, German cohort study on leuprorelin in routine clinical pract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::393ad1b0417a54423941e4b1b041ff9c
https://europepmc.org/articles/PMC8120659/
https://europepmc.org/articles/PMC8120659/
Publikováno v:
Current Therapeutic Research, Clinical and Experimental
Background and objectives This controlled single-blind trial compared the efficacy of a lip balm with propolis special extract GH 2002 at a concentration of 0.5% in the treatment of episodes of herpes labialis with that of 5% aciclovir cream. Methods
Autor:
Rainer Woker, Dirk Müller-Wieland, Bertram Ottillinger, Andreas Hamann, E. G. Siegel, Martin Merkel, Kristian Fresenius
Publikováno v:
International journal of clinical practice. 72(12)
Objectives The objective of this survey was to estimate the prevalence of type 2 diabetes mellitus (T2DM) in hospitalised patients ≥55 years based on routine HbA1c measurement upon admission, using the diagnosis algorithm according to the German Na
Autor:
Dietmar Bulenda, Bertram Ottillinger, Hans Tesch, Ursula Vehling-Kaiser, Matthew Turner, Thomas Ulshöfer
Publikováno v:
Oncology Research and Treatment. 38:146-152
Background: Biosimilars are similar but non-identical versions of existing biological drugs. The HEXAFIL study was an observational study that assessed the clinical usage, safety and efficacy of the biosimilar filgrastim in routine clinical practice
Publikováno v:
Wiener Medizinische Wochenschrift (1946)
Summary STW 5 (Iberogast®; Steigerwald Arzneimittelwerk GmbH, Darmstadt, Germany) contains nine plant extracts and possesses well-documented overall efficacy in functional gastrointestinal disorders (FGID). Little is known about the onset of symptom